Sage Therapeutics, Inc.
NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS
Last updated:
Abstract:
Formulations of comprising a neuroactive steroid, e.g., allopregnanolone; and optionally a cyclodextrin, e.g., a .beta.-cyclodextrin, e.g., a sulfo butyl ether .beta.-cyclodextrin, e.g., a .beta.-cyclodextrin, e.g., a sulfo butyl ether .beta.-cyclodextrin, e.g., CAPTISOL.RTM.; and methods of use in treating CNS disorders.
Status:
Application
Type:
Utility
Filling date:
26 Apr 2019
Issue date:
15 Aug 2019